| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.iolcp.com | |
| Market Cap | 2,343.82 Cr. | |
| Enterprise Value(EV) | 2,342.98 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 29.23 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 13.66 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 274.73 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.45 | Calculated using Price: 399.25 |
| Dividend Yield | 1.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 5.87 Cr. | 58,705,502 Shares |
| FaceValue | 10 | |
| About IOL Chemicals And Pharmaceuticals Ltd. | ||
| IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike. | ||
| 1 Day |
|
-0.21% |
| 1 Week |
|
+2.69% |
| 1 Month |
|
+3.35% |
| 3 Month |
|
-8.18% |
| 6 Month |
|
-3.06% |
| 1 Year |
|
-1.19% |
| 2 Year |
|
-17.10% |
| 5 Year |
|
+113.41% |
| 10 Year |
|
+1675.56% |
| 2 years | 2022-03 | 2023-03 | |
| Return on Equity (%) | 12.04 | 9.6 | |
| Return on Capital Employed (%) | 16.25 | 13.57 | |
| Return on Assets (%) | 8.28 | 6.8 |
| Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 1,392 | 1,508 | 1,590 | |
| Non Curr. Liab. | 57 | 58 | 62 | |
| Curr. Liab. | 575 | 503 | 430 | |
| Minority Int. | ||||
| Equity & Liab. | 2,024 | 2,068 | 2,081 | |
| Non Curr. Assets | 881 | 1,102 | 1,162 | |
| Curr. Assets | 1,143 | 967 | 919 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 2,024 | 2,068 | 2,081 |
| Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 2,184 | 2,217 | 2,216 | |
| Other Income | 32 | 26 | 31 | |
| Total Income | 2,216 | 2,243 | 2,247 | |
| Total Expenditure | -1,926 | -1,991 | -1,940 | |
| PBIDT | 290 | 251 | 308 | |
| Interest | -8 | -16 | -18 | |
| Depreciation | -43 | -46 | -59 | |
| Taxation | -57 | -50 | -60 | |
| Exceptional Items | -14 | |||
| PAT | 168 | 139 | 172 | |
| Minority Interest | ||||
| Share Associate | ||||
| Other Related Items | ||||
| Consolidated Net Profit | 168 | 139 | 172 | |
| Adjusted EPS | 29 | 24 | 29 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 93 | 122 | |
| Cash Fr. Inv. | -121 | -120 | |
| Cash Fr. Finan. | -2 | -4 | |
| Net Change | -29 | -2 | |
| Cash & Cash Eqvt | 3 | 1 |
|
Wed, 24 Apr 2024
Loss/Duplicate-Share Certificate-XBRL IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Loss of share certificates |
|
Wed, 24 Apr 2024
Loss of Share Certificates IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Loss of Share Certificates |
|
Tue, 09 Apr 2024
Disclosure under SEBI Takeover Regulations Varinder Guptaￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ |
| Thu, 25 Apr 2024 |
Close Within 52 Week Low Zone
|
High Increase in 5 Years
|
CCI Bearish
|
Close Above Last Week High
|
| Wed, 24 Apr 2024 |
Higher Delivery Quantity
|
